Alicic RZ, Rooney MT, Tuttle KR (2017) Diabetic kidney disease: challenges, progress, and possibilities. Clinical J Am Soc Nephrol : CJASN 12(12):2032–2045. https://doi.org/10.2215/cjn.11491116
Thomas MC, Brownlee M, Susztak K et al (2015) Diabetic kidney disease. Nat Rev Dis Prim 1:15018. https://doi.org/10.1038/nrdp.2015.18
Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L (2001) The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 44(9):1148–1154. https://doi.org/10.1007/s001250100615
Article CAS PubMed Google Scholar
An Y, Xu BT, Wan SR et al (2023) The role of oxidative stress in diabetes mellitus-induced vascular endothelial dysfunction. Cardiovasc Diabetol 22(1):237. https://doi.org/10.1186/s12933-023-01965-7
Article PubMed PubMed Central Google Scholar
Zhang AH, Zhong H, Tang W et al (2008) Establishing a renal management clinic in China: initiative, challenges, and opportunities. Int Urol Nephrol 40(4):1053–1058. https://doi.org/10.1007/s11255-008-9450-8
Yang J, Liu Z (2022) Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol 13:816400. https://doi.org/10.3389/fendo.2022.816400
Adler AI, Stratton IM, Neil HA et al (2000) Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ (Clin Res ed) 321(7258):412–419. https://doi.org/10.1136/bmj.321.7258.412
Savelieff MG, Callaghan BC, Feldman EL (2020) The emerging role of dyslipidemia in diabetic microvascular complications. Curr Opin Endocrinol Diabetes Obes 27(2):115–123. https://doi.org/10.1097/med.0000000000000533
Article CAS PubMed Google Scholar
Lloyd-Jones DM, Allen NB, Anderson CAM et al (2022) Life’s essential 8: updating and enhancing the American heart association’s construct of cardiovascular health: a presidential advisory from the American heart association. Circulation 146(5):e18–e43. https://doi.org/10.1161/cir.0000000000001078
Article PubMed PubMed Central Google Scholar
Ning N, Zhang Y, Liu Q et al (2023) American heart association’s new “Life’s Essential 8” score in association with cardiovascular disease: a national cross-sectional analysis. Public Health 225:336–342. https://doi.org/10.1016/j.puhe.2023.10.027
Article CAS PubMed Google Scholar
Dong X, Liao L, Wang Y et al (2024) Association between the American heart association’s new “Life’s Essential 8” metrics and kidney stone. World J Urol 42(1):199. https://doi.org/10.1007/s00345-024-04867-9
Article PubMed PubMed Central Google Scholar
Classification and Diagnosis of Diabetes (2020) Standards of medical care in diabetes-2020. Diabetes Care 43(Suppl 1):S14-s31. https://doi.org/10.2337/dc20-S002
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4s):S1–S276. https://doi.org/10.1016/j.kint.2021.05.021
Huang P, Mai Y, Zhao J, Yi Y, Wen Y (2024) Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults. Inflamm Res : Off J Eur Histamine Res Soc [et al] 73(4):655–667. https://doi.org/10.1007/s00011-024-01861-0
Guo Q, Wang Y, Liu Y et al (2024) Association between the cardiometabolic index and chronic kidney disease: a cross-sectional study. Int Urol Nephrol 56(5):1733–1741. https://doi.org/10.1007/s11255-023-03888-4
Mai Y, Yi Y, Wen Y, Huang P, Wang Y, Wang Z (2024) Associations between serum 25-hydroxyvitamin D and prognosis of chronic kidney disease: a prospective cohort study. Int Urol Nephrol. https://doi.org/10.1007/s11255-024-04083-9
Gao J, Liu Y, Ning N et al (2023) Better life’s essential 8 is associated with lower risk of diabetic kidney disease: a community-based study. J Am Heart Assoc 12(17):e029399. https://doi.org/10.1161/jaha.123.029399
Article PubMed PubMed Central Google Scholar
Wang H, Gao L, Zhao C et al (2024) The role of PI3K/Akt signaling pathway in chronic kidney disease. Int Urol Nephrol. https://doi.org/10.1007/s11255-024-03989-8
Article PubMed PubMed Central Google Scholar
Lai W, Xie Y, Zhao X et al (2023) Elevated systemic immune inflammation level increases the risk of total and cause-specific mortality among patients with chronic kidney disease: a large multi-center longitudinal study. Inflamm Res : Off J Eur Histamine Res Soc [et al] 72(1):149–158. https://doi.org/10.1007/s00011-022-01659-y
Ying C, Zhou Z, Dai J et al (2022) Activation of the NLRP3 inflammasome by RAC1 mediates a new mechanism in diabetic nephropathy. Inflamm Res : Off J Eur Histamine Res Soc [et al] 71(2):191–204. https://doi.org/10.1007/s00011-021-01532-4
Huang ZG, Gao JW, Zhang HF et al (2024) Cardiovascular health metrics defined by Life’s Essential 8 scores and subsequent macrovascular and microvascular complications in individuals with type 2 diabetes: A prospective cohort study. Diabetes Obes Metab. https://doi.org/10.1111/dom.15583
Cheng H, Harris RC (2014) Renal endothelial dysfunction in diabetic nephropathy. Cardiovasc Hematol Disord: Drug Targets 14(1):22–33. https://doi.org/10.2174/1871529x14666140401110841
Article CAS PubMed Google Scholar
Alsaad KO, Herzenberg AM (2007) Distinguishing diabetic nephropathy from other causes of glomerulosclerosis: an update. J Clin Pathol 60(1):18–26. https://doi.org/10.1136/jcp.2005.035592
Article CAS PubMed PubMed Central Google Scholar
Janssen U, Riley SG, Vassiliadou A, Floege J, Phillips AO (2003) Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Kidney Int 63(6):2162–2170. https://doi.org/10.1046/j.1523-1755.2003.00007.x
Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A (2015) Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA 313(6):603–615. https://doi.org/10.1001/jama.2014.18574
Article CAS PubMed Google Scholar
Câmara NO, Iseki K, Kramer H, Liu ZH, Sharma K (2017) Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat Rev Nephrol 13(3):181–190. https://doi.org/10.1038/nrneph.2016.191
Eid S, Sas KM, Abcouwer SF et al (2019) New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia 62(9):1539–1549. https://doi.org/10.1007/s00125-019-4959-1
Article PubMed PubMed Central Google Scholar
Huang Y, Zhang X, Li B et al (2023) Association of BMI and waist circumference with diabetic microvascular complications: a prospective cohort study from the UK Biobank and Mendelian randomization analysis. Diabetes Res Clin Pract 205:110975. https://doi.org/10.1016/j.diabres.2023.110975
Hukportie DN, Li FR, Zhou R, Zheng JZ, Wu XX, Wu XB (2022) Waist circumference and body mass index variability and incident diabetic microvascular complications: a post hoc analysis of ACCORD trial. Diabetes Metab J 46(5):767–780. https://doi.org/10.4093/dmj.2021.0258
Article PubMed PubMed Central Google Scholar
Tzamaloukas AH, Murata GH (2005) Prevention of nephropathy in patients with type 2 diabetes mellitus. Int Urol Nephrol 37(3):655–663. https://doi.org/10.1007/s11255-005-2394-3
McMullan CJ, Curhan GC, Forman JP (2016) Association of short sleep duration and rapid decline in renal function. Kidney Int 89(6):1324–1330. https://doi.org/10.1016/j.kint.2015.12.048
Comments (0)